The growing interest in effective weight management has led to considerable investigation into novel treatments. Lately , Retatrutide, a twin-action GIP and glucagon-like peptide-1 (GLP-1) receptor stimulator, has demonstrated promising results in clinical trials, suggesting potential for substantial weight loss . Consequently , several individuals